RNA-Binding Peptide Influences Epitranscriptomic Regulation by Preferentially Binding to Unmodified RNAs Targeted by NSUN2
Biomolecules · 2026
DOI: 10.3390/biom16091287 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Chathurani Ekanayake und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Kent State University, Kent, OH 44242, USA. Hauptthemen laut MEDLINE: Peptides, Methyltransferases, RNA-Binding Proteins, RNA. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
5-Methylcytosine (m5C) is a widespread mRNA modification that regulates gene expression and is frequently dysregulated in cancer. Here, we used phage display to identify peptides that bind an NSUN2 consensus RNA sequence in either its unmodified (UN2-RNA) or m5C-modified (MN2-RNA) form. A single peptide, un2p1 (TDYSTHRLSHSL), was selectively enriched against both targets. Biophysical analyses demonstrated that un2p1 binds this RNA sequence with high affinity and that m5C incorporation reduces binding by approximately ninefold, indicating that cytidine methylation acts as a biochemical switch for peptide–RNA recognition. Sequence alignments mapped un2p1 to a conserved structural loop and catalytic domain region within NSUN2, suggesting that the peptide functions as a molecular mimic of the endogenous RNA-recognition interface. In A549 lung adenocarcinoma cells, un2p1 treatment reduced global m5C levels and downregulated the oncogenic chaperonin CCT5, consistent with disruption of NSUN2-dependent Wnt/β-catenin signaling. These effects were attenuated in non-malignant HEK293 cells, which exhibited a compensatory increase in m5C levels and preserved viability. Together, these findings identify un2p1 as a sequence-specific, methylation-sensitive RNA-binding peptide that modulates the m5C epitranscriptome and selectively impairs lung cancer cell viability, highlighting a substrate-centric strategy for targeting NSUN2-mediated oncogenic pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, Kent State University, Kent, OH 44242, USA.
ORCID-Profile: Chathurani Ekanayake, Aftab Mollah, Sanjaya Abeysirigunawardena
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
Ekanayake, C., Mollah, A., Thompson, M., Hout, E., Thalagaha Mudiyanselage, C., & Abeysirigunawardena, S. (2026). RNA-Binding Peptide Influences Epitranscriptomic Regulation by Preferentially Binding to Unmodified RNAs Targeted by NSUN2. Biomolecules. https://doi.org/10.3390/biom16091287
Vancouver
Ekanayake C, Mollah A, Thompson M, Hout E, Thalagaha Mudiyanselage C, Abeysirigunawardena S. RNA-Binding Peptide Influences Epitranscriptomic Regulation by Preferentially Binding to Unmodified RNAs Targeted by NSUN2. Biomolecules. 2026. doi:10.3390/biom16091287
BibTeX
@article{Ekanayake2026,
author = {Ekanayake, Chathurani and Mollah, Aftab and Thompson, Maelee and Hout, Elizabeth and Thalagaha Mudiyanselage, Chamali and Abeysirigunawardena, Sanjaya},
title = {RNA-Binding Peptide Influences Epitranscriptomic Regulation by Preferentially Binding to Unmodified RNAs Targeted by NSUN2},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16091287}
}
EUVIMED